Tirzepatide, a recently approved medication, is generating significant interest in the healthcare community as a possible treatment for both type 2 diabetes and body composition . This groundbreaking drug works by targeting two different receptors, GLP-1 and GIP, leading to better blood sugar levels and notable fat loss in testing. While preliminar